These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5340022)

  • 1. [Clinical and electromyographic controls of the effect of dopamine in parkinsonian patients].
    Tzavellas O; Umbach W
    Arch Psychiatr Nervenkr (1970); 1967; 209(3):227-40. PubMed ID: 5340022
    [No Abstract]   [Full Text] [Related]  

  • 2. The therapeutic possibilities of L-dopa and amantadine in Parkinsonian patients who have undergone bilateral thalamotomy.
    Giuffrè R; Gambacorta D
    Eur Neurol; 1971; 5(5):311-6. PubMed ID: 4943872
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of L-dopa and stereotaxic surgery in Parkinsonism].
    Sugita K; Mutsuga N; Takaoka Y; Takeda A
    No To Shinkei; 1970 Sep; 22(9):1103-8. PubMed ID: 4918927
    [No Abstract]   [Full Text] [Related]  

  • 4. Stereotaxic intracerebral instillation of dopa.
    Velasco Suárez MM; Escobedo FR
    Confin Neurol; 1970; 32(2):149-57. PubMed ID: 4926179
    [No Abstract]   [Full Text] [Related]  

  • 5. Different effects of drugs before and after stereotaxic operation.
    Umbach W
    Confin Neurol; 1966; 27(1):258-61. PubMed ID: 5334019
    [No Abstract]   [Full Text] [Related]  

  • 6. [Longtime study on the effects of L-dopa therapy in parkinsonism].
    Fischer PA; Schneider E; Jacobi P; Maxion H
    Nervenarzt; 1973 Mar; 44(3):128-35. PubMed ID: 4572536
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dopamine and abnormal movements].
    Rondot P; Dumas RJ
    Rev Neurol (Paris); 1972 Jul; 127(1):99-113. PubMed ID: 4272134
    [No Abstract]   [Full Text] [Related]  

  • 8. [Problems and therapy of L-DOPA-induced dyskinesias].
    Völler GW; Deze J; Gundlach U; Muschard F
    Nervenarzt; 1972 Nov; 43(11):584-6. PubMed ID: 4564994
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of L-dopa on the H-reflex in parkinsonism.
    Fujita S; Cooper IS
    J Am Geriatr Soc; 1971 Apr; 19(4):289-95. PubMed ID: 4936279
    [No Abstract]   [Full Text] [Related]  

  • 10. [Physiopathology and symptomatology of parkinsonian movement disorders in the light of recent therapeutic progress].
    Ferrari E
    Sist Nerv; 1970; 22(2):164-74. PubMed ID: 4926919
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of Parkinson's disease with L-dopa. 77 cases].
    Boudin G; Castaigne P; Lhermitte F; Beck H; Guillard A; Marteau R; Pepin B; Rondot P; Raphy B
    Rev Neurol (Paris); 1970 Feb; 122(2):89-102. PubMed ID: 4931719
    [No Abstract]   [Full Text] [Related]  

  • 12. [2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)].
    Birkmayer W; Linauer W; Mentasti M; Riederer P
    Wien Med Wochenschr; 1974 Jun; 124(22):340-4. PubMed ID: 4275492
    [No Abstract]   [Full Text] [Related]  

  • 13. The decompression reflex of patients with Parkinson's disease before and after stereotaxic operations, and after pharmaceutical treatment.
    Tzavellas O; Gabriel E
    Electroencephalogr Clin Neurophysiol; 1968 Oct; 25(4):395-6. PubMed ID: 4176558
    [No Abstract]   [Full Text] [Related]  

  • 14. Amantadine for Parkinson's disease.
    Mann DC; Pearce LA; Waterbury LD
    Neurology; 1971 Sep; 21(9):958-62. PubMed ID: 4936828
    [No Abstract]   [Full Text] [Related]  

  • 15. [Stereotaxic treatment in extrapyramidal diseases].
    Arseni C; Iacob M; Simionescu M
    Neurol Psihiatr Neurochir; 1973; 18(6):525-38. PubMed ID: 4597684
    [No Abstract]   [Full Text] [Related]  

  • 16. [Electromyographic aspects of laro-dopa therapy].
    Càmpeanu E; Mareş V; Dumitru E; Kory S
    Neurol Psihiatr Neurochir; 1973; 18(6):551-8. PubMed ID: 4790487
    [No Abstract]   [Full Text] [Related]  

  • 17. A quantitative evaluation of the effects of L-dopa on Parkinson's disease.
    Velasco F; Velasco M
    Neuropharmacology; 1973 Feb; 12(2):89-99. PubMed ID: 4595553
    [No Abstract]   [Full Text] [Related]  

  • 18. L-dopa therapy in Parkinson's disease.
    Lipman IJ
    Va Med Mon (1918); 1971 May; 98(5):242-8. PubMed ID: 4931138
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of the Parkinson syndrome with amantadine].
    Hartmann-von Monakow K
    Schweiz Med Wochenschr; 1971 Dec; 101(48):1736-9. PubMed ID: 5140093
    [No Abstract]   [Full Text] [Related]  

  • 20. Akinesis following stereotactic surgery for Parkinsonism. The use of L-dopa.
    Ahmad R; Gillingham FJ; Hanieh A; Pullar IA; Weddell J; Ashcroft G
    Confin Neurol; 1970; 32(2):128-34. PubMed ID: 4926177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.